Lantheus Holding
aPROMISE Receives CE Mark Reports EXINI Diagnostics AB (Subsidiary of Lantheus Holdings)
aPROMISE includes a solution for automated body segmentation and marking, quantifying and reporting suspicious lesions in their anatomical context. The AI tool provides enhanced consistency in quantitative analysis and is intended to increase efficiency, accuracy and reproducibility of PSMA PET/CT image assessments.